Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “gMG”

52 trials

Showing 20 of 52 results

Large-scale testing (Phase 3)Study completedNCT06764160
What this trial is testing

Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMG

Who this might be right for
Generalized Myasthenia Gravis (gMG)Refractory gMG
Alexion Pharmaceuticals, Inc. 15
Not applicableLooking for participantsNCT06967480
What this trial is testing

Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisAnti-AChR Antibody Positive
Alexion Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04146051
What this trial is testing

Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

Who this might be right for
Myasthenia Gravis, Generalized
Cartesian Therapeutics 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05403541
What this trial is testing

Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Immunovant Sciences GmbH 240
Not applicableNot Yet RecruitingNCT07079020
What this trial is testing

Efgartigimod for Consolidation Therapy in gMG

Who this might be right for
Myasthenia Gravis
Da, Yuwei, M.D. 130
Early research (Phase 1)Looking for participantsNCT07215650
What this trial is testing

Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)

Who this might be right for
Generalized Myasthenia Gravis
Candid Therapeutics 44
Post-approval studies (Phase 4)Looking for participantsNCT06909214
What this trial is testing

Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)

Who this might be right for
New Onset Generalized Myasthenia Gravis (gMG)
argenx 30
Large-scale testing (Phase 3)Looking for participantsNCT06463587
What this trial is testing

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Who this might be right for
Generalized Myasthenia Gravis
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 264
Large-scale testing (Phase 3)Study completedNCT04124965
What this trial is testing

Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 71
Large-scale testing (Phase 3)UnknownNCT05716035
What this trial is testing

Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Tang-Du Hospital 64
Large-scale testing (Phase 3)Looking for participantsNCT06744920
What this trial is testing

Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Novartis Pharmaceuticals 180
Large-scale testing (Phase 3)Looking for participantsNCT06607627
What this trial is testing

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisgMG
Alexion Pharmaceuticals, Inc. 12
Large-scale testing (Phase 3)Study completedNCT02301624
What this trial is testing

Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis

Who this might be right for
Refractory Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 117
Large-scale testing (Phase 3)Not Yet RecruitingNCT07215949
What this trial is testing

Zilucoplan for Severe gMG Exacerbations

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Miriam Freimer 15
Large-scale testing (Phase 3)Study completedNCT05681715
What this trial is testing

A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 62
Large-scale testing (Phase 3)Enrolling By InvitationNCT05374590
What this trial is testing

Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisgMG
argenx 12
Not applicableLooking for participantsNCT07247279
What this trial is testing

Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

Who this might be right for
Rare DiseasesGeneralized Myasthenia Gravis (gMG)
AstraZeneca 450
Large-scale testing (Phase 3)Active Not RecruitingNCT05556096
What this trial is testing

Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 261
Testing effectiveness (Phase 2)Ended earlyNCT05218096
What this trial is testing

Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisMyasthenia Gravis
Alexion Pharmaceuticals, Inc. 70
Post-approval studies (Phase 4)Not Yet RecruitingNCT07221838
What this trial is testing

Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

Who this might be right for
Generalized Myasthenia GravisgMG
Alexion Pharmaceuticals, Inc. 75
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation